title: Monitoring for opioid-induced advancing sedation and respiratory depression: ASPMN membership survey of current practice.
abstract: Adverse events secondary to opioid-induced advancing sedation and respiratory depression continue to occur during hospitalizations despite efforts to increase awareness and clinical practice guidelines to address prevention strategies. In 2009, ASPMN surveyed membership on current practices surrounding this topic. ASPMN clinical practice guidelines were then published in 2011. In winter of 2013, ASPMN membership was again surveyed to assess progress in preventing adverse events. This is a report of the follow-up membership survey. In general, monitoring practices are slowly improving over time, but there are many facilities that have not instituted best practices for avoiding adverse events.
authors.affiliation: School of Nursing, University at Buffalo, Buffalo, New York. Electronic address: CarlaJun@Buffalo.edu.
authors.forename: Carla R
authors.initials: CR
authors.lastname: Jungquist
authors.affiliation: College of Nursing, Villanova University, Villanova, Pennsylvania.
authors.forename: Joyce S
authors.initials: JS
authors.lastname: Willens
authors.affiliation: School of Nursing, University at Buffalo, Buffalo, New York; Acute Pain Service, Halton Healthcare Services, Oakville, Ontario.
authors.forename: Danielle R
authors.initials: DR
authors.lastname: Dunwoody
authors.affiliation: School of Nursing, University at Buffalo, Buffalo, New York; Lifetime Care, Home Health Care and Hospice, Rochester, New York.
authors.forename: Karen J
authors.initials: KJ
authors.lastname: Klingman
authors.affiliation: University of Pennsylvania School of Nursing and Perelman School of Medicine, Philadelphia, Pennsylvania.
authors.forename: Rosemary C
authors.initials: RC
authors.lastname: Polomano
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D009741:Nursing Staff, Hospital / Q000592:standards*; D010146:Pain / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000451:nursing; D012308:Risk Management; D012956:Societies, Nursing / Q000592:standards; D014481:United States
chemical_list: D000701:Analgesics, Opioid